Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

SOMNOMED LIMITED

INVESTOR PRESENTATION - SOMNOMED LIMITED

ASX:SOM

SOMNOMED LIMITED

Health Care

SomnoMed Limited (SOM) provides diagnostic and treatment solutions for Sleep-related Breathing Disorders including obstructive sleep apnea, snoring and bruxism. SomnoDent provides medical oral appliance therapy for over 300,000 patients in 27 countries. Former Names --

Market Cap

192.83m

Price at Close

$2.33

4w avg. Volume

98.29k

4w avg. Turnover

$198.08k

Announcements
announcementt+2 movementdate
  • Corporate Governance Statement & Appendix 4G

    Periodic Reports

  • -

    27 Sep 2020

-

27 Sep 2020
  • Annual Report to shareholders

    Periodic Reports

  • -

    27 Sep 2020

-

27 Sep 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • +23.27%

    01 Sep 2020

+23.27%

01 Sep 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • +4.40%

    31 Aug 2020

+4.40%

31 Aug 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • +1.60%

    28 Aug 2020

+1.60%

28 Aug 2020
  • Change of auditor notification

    Company Administration

  • +1.60%

    28 Aug 2020

+1.60%

28 Aug 2020
  • Initial Director's Interest Notice

    Shareholder Details

  • -0.65%

    24 Aug 2020

-0.65%

24 Aug 2020
  • Initial Director's Interest Notice

    Shareholder Details

  • -0.65%

    24 Aug 2020

-0.65%

24 Aug 2020
  • Initial Director's Interest Notice

    Shareholder Details

  • -0.65%

    24 Aug 2020

-0.65%

24 Aug 2020
  • Initial Director's Interest Notice

    Shareholder Details

  • -0.65%

    24 Aug 2020

-0.65%

24 Aug 2020
Market Data

Current Price

$2.33

52WK HIGH

$3.44

52WK LOW

$0.9

1YR RETURN

+3.10%

1YR RETURN VS. SECTOR

-43.87%

90 DAY RETURN

+97.46%

ASX RANK

563

/2,020

SECTOR RANK

5

/28

SHARES OUTSTANDING

82.76m
ASX:SOM

SOMNOMED LIMITED

Health Care

SomnoMed Limited (SOM) provides diagnostic and treatment solutions for Sleep-related Breathing Disorders including obstructive sleep apnea, snoring and bruxism. SomnoDent provides medical oral appliance therapy for over 300,000 patients in 27 countries. Former Names --

Market Cap

192.83m

Price at Close

$2.33

4w avg. Volume

98.29k

4w avg. Turnover

$198.08k

ASX:SOM is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.